BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16814757)

  • 1. Biology of atherosclerotic plaques: what we are learning from proteomic analysis.
    Blanco-Colio LM; Martín-Ventura JL; Vivanco F; Michel JB; Meilhac O; Egido J
    Cardiovasc Res; 2006 Oct; 72(1):18-29. PubMed ID: 16814757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
    Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quest for novel cardiovascular biomarkers by proteomic analysis.
    Vivanco F; Martín-Ventura JL; Duran MC; Barderas MG; Blanco-Colio L; Dardé VM; Mas S; Meilhac O; Michel JB; Tuñón J; Egido J
    J Proteome Res; 2005; 4(4):1181-91. PubMed ID: 16083268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification of endothelial proteins isolated in situ from atherosclerotic aorta via systemic perfusion.
    Wu J; Liu W; Sousa E; Qiu Y; Pittman DD; Maganti V; Feldman J; Gill D; Lu Z; Dorner AJ; Schaub R; Tan XY
    J Proteome Res; 2007 Dec; 6(12):4728-36. PubMed ID: 17997517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular proteomics.
    Barderas MG; Vivanco F; Alvarez-Llamas G
    Methods Mol Biol; 2013; 1000():1-20. PubMed ID: 23585080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic strategies in the search of new biomarkers in atherothrombosis.
    Tuñón J; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; López JA; Egido J
    J Am Coll Cardiol; 2010 May; 55(19):2009-16. PubMed ID: 20447523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the human atheroma plaque secretome by proteomic analysis.
    Durán MC; Martín-Ventura JL; Mas S; Barderas MG; Dardé VM; Jensen ON; Egido J; Vivanco F
    Methods Mol Biol; 2007; 357():141-50. PubMed ID: 17172685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.
    Leroyer AS; Rautou PE; Silvestre JS; Castier Y; Lesèche G; Devue C; Duriez M; Brandes RP; Lutgens E; Tedgui A; Boulanger CM
    J Am Coll Cardiol; 2008 Oct; 52(16):1302-11. PubMed ID: 18929241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connexins: new genes in atherosclerosis.
    Chadjichristos CE; Kwak BR
    Ann Med; 2007; 39(6):402-11. PubMed ID: 17852028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases.
    de la Cuesta F; Alvarez-Llamas G; Gil-Dones F; Martin-Rojas T; Zubiri I; Pastor C; Barderas MG; Vivanco F
    Expert Rev Proteomics; 2009 Aug; 6(4):395-409. PubMed ID: 19681675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.
    Blanco-Colio LM; Martín-Ventura JL; Carrero JJ; Yilmaz MI; Moreno JA; Gómez-Guerrero C; Ortiz A; Egido J
    Proteomics Clin Appl; 2011 Jun; 5(5-6):281-8. PubMed ID: 21538911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells and degradation of pericellular and extracellular matrices: potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques.
    Kovanen PT
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):857-61. PubMed ID: 17956232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular biology: cellular and molecular profiling.
    Baird AE; Wright VL
    Semin Neurol; 2006 Feb; 26(1):65-74. PubMed ID: 16479445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of nitric oxide in cardiovascular medicine: untapped potential utility.
    Pepine CJ
    Am J Med; 2009 May; 122(5 Suppl):S10-5. PubMed ID: 19393821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inflammation in atherosclerosis.
    Spagnoli LG; Bonanno E; Sangiorgi G; Mauriello A
    J Nucl Med; 2007 Nov; 48(11):1800-15. PubMed ID: 17942804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
    Rudijanto A
    Acta Med Indones; 2007; 39(2):86-93. PubMed ID: 17933075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events.
    Cola C; Clementi E; Biondi-Zoccai G; Sangiorgi G
    Acta Chir Belg; 2007; 107(2):129-42. PubMed ID: 17515260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.